News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
733,892 Results
Type
Article (44436)
Company Profile (267)
Press Release (689179)
Multimedia
Podcasts (89)
Webinars (17)
Section
Business (206102)
Career Advice (2097)
Deals (35725)
Drug Delivery (119)
Drug Development (82795)
Employer Resources (175)
FDA (16580)
Job Trends (15134)
News (349852)
Policy (33271)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2659)
Accelerated approval (34)
Adcomms (25)
Allergies (147)
Alliances (49915)
ALS (172)
Alzheimer's disease (1685)
Antibody-drug conjugate (ADC) (320)
Approvals (16840)
Artificial intelligence (524)
Autoimmune disease (163)
Automation (42)
Bankruptcy (363)
Best Places to Work (11772)
BIOSECURE Act (20)
Biosimilars (193)
Biotechnology (174)
Bladder cancer (162)
Brain cancer (60)
Breast cancer (648)
Cancer (4909)
Cardiovascular disease (413)
Career advice (1775)
Career pathing (36)
CAR-T (290)
CDC (53)
Celiac Disease (2)
Cell therapy (764)
Cervical cancer (37)
Clinical research (70662)
Collaboration (1726)
Company closure (4)
Compensation (1179)
Complete response letters (59)
COVID-19 (2765)
CRISPR (95)
C-suite (866)
Cystic fibrosis (144)
Data (6343)
Decentralized trials (2)
Denatured (25)
Depression (138)
Diabetes (512)
Diagnostics (6781)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (256)
Drug pricing (198)
Drug shortages (29)
Duchenne muscular dystrophy (235)
Earnings (90448)
Editorial (61)
Employer branding (22)
Employer resources (154)
Events (119448)
Executive appointments (986)
FDA (19743)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1491)
Gene editing (205)
Generative AI (44)
Gene therapy (611)
GLP-1 (998)
Government (4792)
Grass and pollen (6)
Guidances (384)
Healthcare (19263)
HIV (63)
Huntington's disease (45)
IgA nephropathy (84)
Immunology and inflammation (259)
Immuno-oncology (62)
Indications (119)
Infectious disease (3045)
Inflammatory bowel disease (198)
Inflation Reduction Act (14)
Influenza (121)
Intellectual property (256)
Interviews (325)
IPO (16724)
IRA (50)
Job creations (3694)
Job search strategy (1487)
JPM (57)
Kidney cancer (16)
Labor market (87)
Layoffs (553)
Leadership (32)
Legal (8076)
Liver cancer (91)
Longevity (15)
Lung cancer (664)
Lymphoma (384)
Machine learning (42)
Management (60)
Manufacturing (810)
MASH (167)
Medical device (13872)
Medtech (13929)
Mergers & acquisitions (20077)
Metabolic disorders (1302)
Multiple sclerosis (164)
NASH (16)
Neurodegenerative disease (323)
Neuropsychiatric disorders (90)
Neuroscience (2948)
Neurotech (1)
NextGen: Class of 2026 (6660)
Non-profit (4692)
Now hiring (68)
Obesity (614)
Opinion (273)
Ovarian cancer (168)
Pain (202)
Pancreatic cancer (231)
Parkinson's disease (287)
Partnered (33)
Patents (508)
Patient recruitment (499)
Peanut (57)
People (59601)
Pharmaceutical (62)
Pharmacy benefit managers (31)
Phase 1 (21997)
Phase 2 (31049)
Phase 3 (23164)
Pipeline (5470)
Policy (302)
Postmarket research (2698)
Preclinical (9408)
Press Release (65)
Prostate cancer (243)
Psychedelics (48)
Radiopharmaceuticals (288)
Rare diseases (860)
Real estate (6025)
Recruiting (70)
Regulatory (24890)
Reports (53)
Research institute (2442)
Resumes & cover letters (356)
Rett syndrome (27)
RNA editing (16)
RSV (81)
Schizophrenia (151)
Series A (243)
Series B (192)
Service/supplier (11)
Sickle cell disease (103)
Special edition (24)
Spinal muscular atrophy (159)
Sponsored (42)
Startups (3641)
State (2)
Stomach cancer (19)
Supply chain (105)
Tariffs (88)
The Weekly (62)
Vaccines (1036)
Venture capital (89)
Weight loss (396)
Women's health (93)
Worklife (19)
Date
Today (32)
Last 7 days (577)
Last 30 days (2250)
Last 365 days (29964)
2026 (4031)
2025 (30387)
2024 (35480)
2023 (40363)
2022 (51491)
2021 (56026)
2020 (54584)
2019 (47260)
2018 (35570)
2017 (32481)
2016 (32010)
2015 (38089)
2014 (31883)
2013 (27007)
2012 (29252)
2011 (29918)
2010 (28248)
Location
Africa (763)
Alabama (85)
Alaska (7)
Arizona (312)
Arkansas (13)
Asia (39823)
Australia (6573)
California (11433)
Canada (3324)
China (1120)
Colorado (481)
Connecticut (484)
Delaware (341)
Europe (86284)
Florida (1713)
Georgia (363)
Hawaii (3)
Idaho (61)
Illinois (883)
India (70)
Indiana (528)
Iowa (23)
Japan (436)
Kansas (128)
Kentucky (41)
Louisiana (26)
Maine (72)
Maryland (1406)
Massachusetts (8228)
Michigan (329)
Minnesota (633)
Mississippi (5)
Missouri (129)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (81)
New Jersey (3045)
New Mexico (29)
New York (3016)
North Carolina (1478)
North Dakota (9)
Northern California (5597)
Ohio (338)
Oklahoma (21)
Oregon (41)
Pennsylvania (2310)
Puerto Rico (24)
Rhode Island (49)
South America (1155)
South Carolina (67)
South Dakota (1)
Southern California (4454)
Tennessee (178)
Texas (1762)
United States (40619)
Utah (342)
Vermont (1)
Virginia (265)
Washington D.C. (82)
Washington State (932)
West Virginia (4)
Wisconsin (113)
Wyoming (2)
733,892 Results for "american regent inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
Moderna’s mRNA Tech Could Boost Flu Shot Efficacy. Americans Will Have To Wait
After the FDA’s decision to reject a review of Moderna’s mRNA-1010 flu shot, executives explain what Americans will miss out on as other nations embrace the technology.
February 16, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Society for Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2026
January 7, 2026
·
3 min read
Opinion
Policymakers Must Sustain American Life Sciences Leadership
Maintaining America’s momentum demands that policymakers resist policies that undermine research and development incentives.
February 20, 2026
·
4 min read
·
Dan Leonard
Press Releases
Izotropic Revises License Agreement with The Regents of the University of California
June 10, 2025
·
4 min read
Press Releases
American Regent introduces FDA-approved Epinephrine Injection, USP in 30 mL
October 29, 2024
·
8 min read
Press Releases
Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
December 19, 2025
·
2 min read
Policy
American Regent Introduces Potassium Phosphates, USP; FDA-Approved and “AP” Rated¹
American Regent announces the launch and availability of Potassium Phosphates Injection, USP, which is FDA-approved and therapeutically equivalent to Potassium Phosphates.1 Potassium Phosphates Injection, USP is indicated as a source of phosphorus:
October 19, 2023
·
9 min read
Pharm Country
American Regent Introduces Levocarnitine Injection, USP; FDA-Approved, AP Rated, and Therapeutically Equivalent to Carnitor®¹
American Regent announces the release and availability of Levocarnitine Injection, USP, FDA-approved, “AP” rated, and therapeutically equivalent to Carnitor®.
October 10, 2023
·
6 min read
Drug Development
American Regent Announces Results From Phase 3 HEART-FID Trial with INJECTAFER®
American Regent, Inc., a Daiichi Sankyo Group company, announced results from the phase 3 HEART-FID trial of INJECTAFER® for the treatment of iron deficiency in adult heart failure patients with reduced ejection fraction.
August 26, 2023
·
12 min read
Press Releases
NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards
October 20, 2025
·
2 min read
1 of 73,390
Next
